LOIS TRAVIS was named the Lawrence H. Einhorn Professor of Cancer Research at the Indiana University School of Medicine and director of the Cancer Survivorship Research Program at the IU Melvin and Bren Simon Cancer Center.
Travis is also a member of the cancer center’s Cancer Prevention and Control research program, which focuses on prevention, early detection and survivorship, and she will also hold an academic appointment in the Department of Epidemiology at the IU Richard M. Fairbanks School of Public Health.
In addition, Travis is the principal investigator of an NIH study that aims to identify genetic variants associated with cisplatin-related toxicities, and focuses on testicular cancer patients previously treated at the IU Simon Cancer Center and other major cancer centers.
Previously, Travis was the director of the Rubin Center for Cancer Survivorship and chief of the Division of Cancer Survivorship at the University of Rochester Medical Center. She also was a senior principal investigator and lead research investigator at the NCI, where for nearly 20 years she conducted international studies of late treatment effects in cancer survivors, with an emphasis on second malignant neoplasms.
